Print previewpersonal data approved: 2013. V. 16.
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
| Publications |
2013
 manual entry, 2013. IV. 23. |
Kremlitzka M, Polgár A, Fülöp L, Kiss E, Poór G, Erdei A.: Complement receptor type 1 (CR1, CD35) is a potent inhibitor of B-cell functions in rheumatoid arthritis patients., International Journal of Immunology, pp. 25-33 type of document: Journal paper/Article impact factor: 3.415 language: English
|
2012
 manual entry, 2013. IV. 23. |
Torok K, Kremlitzka M, Sandor N, Toth EA, Bajtay Z, Erdei A: Human T cell derived, cell-bound complement iC3b is integrally involved in T cell activation, Immunology Letters, pp. 131-136 type of document: Journal paper/Article impact factor: 2.526 language: English
|
2010
 manual entry, 2010. IX. 27. |
Prechl J, Papp K, Erdei A.: Antigen microarrays: descriptive chemistry or functional immunomics?, Trends Immunol., pp. 133-137 type of document: Journal paper/Review paper impact factor: 9.700 language: English
|
2009
 manual entry, 2013. IV. 23. |
Terenyi N, Nagy N, Papp K, Prechl J, Olah I, Erdei A: Transient decomplementation of mice delays onset of experimental autoimmune encephalomyelitis and impairs MOG-specific T cell response and autoantibody production, Molecular Immunology, pp. 57-63 type of document: Journal paper/Article impact factor: 3.202 number of independent citations: 4 language: English
|
2009
 manual entry, 2013. IV. 23. |
Erdei A, Isaak A, Torok K, Sandor N, Kremlitzka M, Prechl J, Bajtay Z: Expression and role of CR1 and CR2 on B and T lymphocytes under physiological and autoimmune conditions, Mol Immunol., pp. 2767-2773 type of document: Journal paper/Article impact factor: 3.202 number of independent citations: 12 language: English
|
2004
 manual entry, 2013. IV. 23. |
Dimitrios Mastellos, József Prechl, Glória László, Krisztián Papp, Eszter Oláh, Emelia Argyropoulos, Silvia Franchini, Ruxandra Tudoran, Maciej Markiewski, John D. Lambris, Anna Erdei: Novel monoclonal antibodies against mouse C3 interfering with complement activation: Description of fine specificit y and applications to various immunoassays, Molecular Immunology, 2004, 40: 1213-1221, pp. 1213-1221 type of document: Journal paper/Article impact factor: 3.196 number of independent citations: 25 language: English
|
2003
 manual entry, 2013. IV. 23. |
Anna Erdei, József Prechl, Andrea Isaák, Eszter Molnár: Regulation of B cell activation by complement receptors CD21 and CD35, Current Pharmaceutical Design, 23:1849-60., pp. 1849-1860 type of document: Journal paper/Review paper impact factor: 5.500 number of independent citations: 19 language: English
|
1991
 manual entry, 2013. IV. 23. |
Anna Erdei, G.Füst and J.Gergely: The role of C3 in the immune response, Immunology Today, 1991. 168(6), 2782-2788, pp. 2782-2788 type of document: Journal paper/Review paper impact factor: 17.900 number of independent citations: 111 language: English
|
1985
 manual entry, 2013. IV. 23. |
F.Melchers, Anna Erdei, T.Schulz and M.P.Dierich: Growth control of activated, synchronized murine B cells by the C3d fragment of human complement, Nature, 1985. 317, 264-267., pp. 264-223 type of document: Journal paper/Article impact factor: 12.860 number of independent citations: 225 language: English
|
1985
 manual entry, 2013. IV. 23. |
P.Somogyi, A.J.Hodgson, I.W.Chubb, B.Penke and Anna Erdei: Antisera to gamma-aminobutyric acid., The Journal of Histochemistry and Cytochemistry, 33, 240-248., pp. 240-248 type of document: Journal paper/Article impact factor: 3.340 number of independent citations: 383 language: English
|
| | Cumulative impact factor of the 10 most significant publications: | 64.841  |
| | Number of independent citations to these publications: | 779  |
|
|
 |
|
|